Logo image of BNZI

BANZAI INTERNATIONAL INC (BNZI) Stock Fundamental Analysis

NASDAQ:BNZI - Nasdaq - US06682J3086 - Common Stock - Currency: USD

1.02  +0.03 (+2.51%)

After market: 1.02 0 (0%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to BNZI. BNZI was compared to 285 industry peers in the Software industry. BNZI may be in some trouble as it scores bad on both profitability and health. BNZI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BNZI had negative earnings in the past year.
In multiple years BNZI reported negative net income over the last 5 years.
BNZI had a negative operating cash flow in each of the past 5 years.
BNZI Yearly Net Income VS EBIT VS OCF VS FCFBNZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

BNZI's Return On Assets of -197.03% is on the low side compared to the rest of the industry. BNZI is outperformed by 93.33% of its industry peers.
Industry RankSector Rank
ROA -197.03%
ROE N/A
ROIC N/A
ROA(3y)-83.21%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNZI Yearly ROA, ROE, ROICBNZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200

1.3 Margins

BNZI has a Gross Margin (68.33%) which is in line with its industry peers.
BNZI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BNZI Yearly Profit, Operating, Gross MarginsBNZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

BNZI does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for BNZI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BNZI Yearly Shares OutstandingBNZI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
BNZI Yearly Total Debt VS Total AssetsBNZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

BNZI has an Altman-Z score of -21.09. This is a bad value and indicates that BNZI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -21.09, BNZI is doing worse than 93.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.09
ROIC/WACCN/A
WACC12.08%
BNZI Yearly LT Debt VS Equity VS FCFBNZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

BNZI has a Current Ratio of 0.17. This is a bad value and indicates that BNZI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.17, BNZI is not doing good in the industry: 94.39% of the companies in the same industry are doing better.
BNZI has a Quick Ratio of 0.17. This is a bad value and indicates that BNZI is not financially healthy enough and could expect problems in meeting its short term obligations.
BNZI has a worse Quick ratio (0.17) than 94.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
BNZI Yearly Current Assets VS Current LiabilitesBNZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y96.42%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year385.49%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNZI Yearly Revenue VS EstimatesBNZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 5M 10M 15M 20M
BNZI Yearly EPS VS EstimatesBNZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BNZI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BNZI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNZI Price Earnings VS Forward Price EarningsBNZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BNZI Per share dataBNZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BNZI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BANZAI INTERNATIONAL INC

NASDAQ:BNZI (4/22/2025, 8:00:00 PM)

After market: 1.02 0 (0%)

1.02

+0.03 (+2.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15/amc
Earnings (Next)05-13 2025-05-13
Inst Owners3.36%
Inst Owner Change0%
Ins Owners7.28%
Ins Owner Change0%
Market Cap15.46M
Analysts82.5
Price Target17.34 (1600%)
Short Float %3.19%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.25%
Min EPS beat(2)-13.12%
Max EPS beat(2)41.61%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.35%
Min Revenue beat(2)-11.76%
Max Revenue beat(2)-10.93%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-86.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)96%
EPS NY rev (1m)0%
EPS NY rev (3m)82.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-24.22
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.3
BVpS-1.51
TBVpS-1.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -197.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.33%
FCFM N/A
ROA(3y)-83.21%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -21.09
F-ScoreN/A
WACC12.08%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y96.42%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year385.49%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-202.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.54%
OCF growth 3YN/A
OCF growth 5YN/A